Search details
1.
Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone neuroprotective properties.
BMC Neurosci
; 19(Suppl 1): 13, 2018 04 19.
Article
in English
| MEDLINE | ID: mdl-29745864
2.
New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes.
Neurochem Res
; 41(3): 620-30, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26376806
3.
The Aß-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain.
J Neurochem
; 130(3): 419-31, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24528201
4.
Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress.
Clin Sci (Lond)
; 126(7): 507-16, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24147777
5.
Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?
J Neurochem
; 120 Suppl 1: 167-185, 2012 Jan.
Article
in English
| MEDLINE | ID: mdl-22122230
6.
The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells.
Int J Cancer
; 130(4): 775-86, 2012 Feb 15.
Article
in English
| MEDLINE | ID: mdl-21365649
7.
The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway.
J Biol Chem
; 285(53): 41443-54, 2010 Dec 31.
Article
in English
| MEDLINE | ID: mdl-20961856
8.
Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease.
EMBO Rep
; 10(1): 94-100, 2009 Jan.
Article
in English
| MEDLINE | ID: mdl-19057576
9.
A microRNA-based gene dysregulation pathway in Huntington's disease.
Neurobiol Dis
; 29(3): 438-45, 2008 Mar.
Article
in English
| MEDLINE | ID: mdl-18082412
10.
Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease.
Curr Alzheimer Res
; 5(2): 212-24, 2008 Apr.
Article
in English
| MEDLINE | ID: mdl-18393806
11.
Mediator: the missing link in amyloid precursor protein nuclear signalling.
EMBO Rep
; 12(3): 180-1, 2011 Mar.
Article
in English
| MEDLINE | ID: mdl-21368841
12.
Distinct profiles of REST interactions with its target genes at different stages of neuronal development.
Mol Biol Cell
; 16(12): 5630-8, 2005 Dec.
Article
in English
| MEDLINE | ID: mdl-16195345
13.
Interaction of the repressor element 1-silencing transcription factor (REST) with target genes.
J Mol Biol
; 334(5): 863-74, 2003 Dec 12.
Article
in English
| MEDLINE | ID: mdl-14643653
14.
Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.
Front Aging Neurosci
; 6: 235, 2014.
Article
in English
| MEDLINE | ID: mdl-25278875
15.
Nuclear signalling by membrane protein intracellular domains: the AICD enigma.
Cell Signal
; 24(2): 402-409, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-22024280
16.
Effect of sodium valproate administration on brain neprilysin expression and memory in rats.
J Mol Neurosci
; 46(3): 569-77, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-21932040
17.
Sodium valproate: an old drug with new roles.
Trends Pharmacol Sci
; 30(10): 509-14, 2009 Oct.
Article
in English
| MEDLINE | ID: mdl-19762089
18.
BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression.
J Biol Chem
; 281(51): 38974-80, 2006 Dec 22.
Article
in English
| MEDLINE | ID: mdl-17023429
19.
Centromere-specific acetylation of histone H4 in barley detected through three-dimensional microscopy.
Plant Mol Biol
; 51(4): 533-41, 2003 Mar.
Article
in English
| MEDLINE | ID: mdl-12650619
20.
Cell cycle-dependent and lysine residue-specific dynamic changes of histone H4 acetylation in barley.
Plant Mol Biol
; 49(6): 645-53, 2002 Aug.
Article
in English
| MEDLINE | ID: mdl-12081372